U.S. Markets close in 3 hrs 14 mins
  • S&P 500

    4,251.29
    +44.02 (+1.05%)
     
  • Dow 30

    33,603.77
    +267.10 (+0.80%)
     
  • Nasdaq

    12,957.58
    +177.66 (+1.39%)
     
  • Russell 2000

    2,005.56
    +30.30 (+1.53%)
     
  • Crude Oil

    92.43
    -1.91 (-2.02%)
     
  • Gold

    1,813.60
    +6.40 (+0.35%)
     
  • Silver

    20.52
    +0.17 (+0.84%)
     
  • EUR/USD

    1.0262
    -0.0064 (-0.6157%)
     
  • 10-Yr Bond

    2.8690
    -0.0190 (-0.66%)
     
  • Vix

    19.14
    -1.06 (-5.25%)
     
  • GBP/USD

    1.2131
    -0.0071 (-0.5823%)
     
  • USD/JPY

    133.5710
    +0.5720 (+0.4301%)
     
  • BTC-USD

    24,005.25
    -321.62 (-1.32%)
     
  • CMC Crypto 200

    570.31
    -0.97 (-0.17%)
     
  • FTSE 100

    7,500.89
    +34.98 (+0.47%)
     
  • Nikkei 225

    28,546.98
    +727.65 (+2.62%)
     

Natus Medical to Hold 2021 Fourth Quarter Financial Results Conference Call on February 25th

·1 min read

PLEASANTON, Calif., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced today that the Company will release its 2021 fourth quarter financial results after the close of the market on Thursday, February 24th. Natus management will host a conference call on Friday, February 25th at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time) to discuss those results and to answer questions.

Individuals interested in listening to the conference call may do so by dialing 1-844-634-1441 for domestic callers, or 1-508-637-5658 for international callers, and entering reservation code 6682846. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 1-855-859-2056 for domestic callers, or 1-404-537-3406 for international callers, and entering reservation code 6682846.

The conference call also will be available real-time via the Internet at http://investor.natus.com and a recording of the call will be available on the Company's Web site for 90 days following the completion of the call.

About Natus Medical Incorporated

Natus is a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages.

Additional information about Natus Medical can be found at www.natus.com.

COMPANY CONTACT:
Natus Medical Incorporated
Drew Davies
Executive Vice President and Chief Financial Officer
(925) 223-6700
InvestorRelations@Natus.com